{
    "2020-03-06": [
        [
            {
                "time": "",
                "orginal_text": "疫情下布局，不错！自研抗癌药红利期将过，贝达药业拟募资10亿攻新药",
                "features": {
                    "keywords": [
                        "疫情",
                        "布局",
                        "自研抗癌药",
                        "红利期",
                        "贝达药业",
                        "募资",
                        "新药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "贝达药业：三家股东累计减持2.1%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "贝达药业(300558.SZ)：3名股东已合计减持844.08万股 减持数量过半 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持",
                        "数量过半"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "贝达药业上市后研发增近三倍 募资10亿加快新药上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "上市",
                        "研发",
                        "募资",
                        "新药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}